Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
NCT ID: NCT07140757
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2026-02-04
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
NCT05003856
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
NCT04129411
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
NCT06929650
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
NCT07226804
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
NCT00103155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
• To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care
Secondary Objectives
* To establish the health-related quality of life among participants undergoing with ultrasound guided RFA.
* To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA.
* To assess adverse events rates following ultrasound guided RFA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2. Participants considered unsuitable for RFA by the treating physician
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victoria E Banuchi, MD
Role: STUDY_DIRECTOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-06179
Identifier Type: OTHER
Identifier Source: secondary_id
2025-0083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.